Checkmate Pharmaceuticals
Cambridge
About Checkmate Pharmaceuticals
Checkmate Pharma is a clinical-stage biopharmaceutical company developing a new approach for cancer immunotherapy. The clinical programs are focused on enabling more people with cancer to benefit from the promise of novel immunotherapies. They leveraging their expertise in the field of CpG oligonucleotides to discover and develop immunotherapies designed to increase the efficacy of existing immunotherapies and to provide new treatment options for patients and their healthcare providers. Checkmate Pharmaceutical was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $170.0M
- Funding stage: M&A
- Last round: Series C (Jun 2020)
- Ticker: nasdaq:CMPI
- Website: checkmatepharma.com
- Phone: (617) 682-3625
Industries & Categories
Biotechnology, Medical Device, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/checkmate-pharmaceuticals-2221481 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.